Eli Lilly Surges $170 Billion in Market Value with Zepbound
Eli Lilly & Co. skyrockets over $170 billion in market value as demand for its Zepbound drug soars, showcasing impressive growth and investment potential.
Eli Lilly & Co. added more than $170 billion to its market value due to demand for its Zepbound drug.